|
Volumn 45, Issue 5, 2010, Pages 963-965
|
Extracorporeal photochemotherapy as second- or first-line therapy of acute GVHD
a,b,c a,b a,b a,b a,b a,b a,b,c a,b,c
a
HÔTEL DIEU
(France)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
BUSULFAN;
CORTICOSTEROID DERIVATIVE;
CYCLOSPORIN A;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PENTOSTATIN;
THYMOCYTE ANTIBODY;
ACUTE GRAFT VERSUS HOST DISEASE;
ADOLESCENT;
ADULT;
CHILD;
CHRONIC GRAFT VERSUS HOST DISEASE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DEATH;
DRUG WITHDRAWAL;
EVENT FREE SURVIVAL;
EXTRACORPOREAL PHOTOCHEMOTHERAPY;
FOLLOW UP;
HEMATOLOGIC MALIGNANCY;
HUMAN;
LETTER;
MULTIPLE ORGAN FAILURE;
NONMYELOABLATIVE STEM CELL TRANSPLANTATION;
OVERALL SURVIVAL;
PHOTOCHEMOTHERAPY;
PRIORITY JOURNAL;
TREATMENT INDICATION;
TREATMENT OUTCOME;
ULTRAVIOLET A RADIATION;
UNSPECIFIED SIDE EFFECT;
WHOLE BODY RADIATION;
ACUTE DISEASE;
ADOLESCENT;
CHILD;
CHILD, PRESCHOOL;
GRAFT VS HOST DISEASE;
HEMATOLOGIC NEOPLASMS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
INFANT;
PHOTOPHERESIS;
RECURRENCE;
TREATMENT OUTCOME;
|
EID: 77952420234
PISSN: 02683369
EISSN: 14765365
Source Type: Journal
DOI: 10.1038/bmt.2009.271 Document Type: Letter |
Times cited : (17)
|
References (5)
|